reference/8163075

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8163075

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1689
issn	1557-3265 1078-0432
issueIdentifier	7
pageRange	1678-1689
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	1678
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0800f83fec9d5028489f572f0a35022c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_336ae0a312865ff4263b48641de3fde5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a4a4d52950e33267ecdc80a8f3c095ea
bibliographicCitation	Nouri M, Massah S, Caradec J, Lubik AA, Li N, Truong S, Lee AR, Fazli L, Ramnarine VR, Lovnicki JM, Moore J, Wang M, Foo J, Gleave ME, Hollier BG, Nelson C, Collins C, Dong X, Buttyan R. Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer. Clin Cancer Res. 2020 Apr 01;26(7):1678–89. doi: 10.1158/1078-0432.ccr-19-0098. PMID: 31919137.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06cbaf6ac182fb64c946944889da6933 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3acd2ec9c3aa2f713697b9de6d3ee568 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_affcc3dd2671b9dc79322abf8741b1d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_154eeff74c9a5fa4f204371c2ead441b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dae84ea2cb35648421272b7963e720e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a18dd4222fe77f7fb1d09f245d5299d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36a340dfd8962b1701af3baf0fc24988 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b43f9d63c5747ef2e7d456979874c57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e9f9a7513a4df7c47be6d9d00041040 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10a379607b887abad77cf35938c01527 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62bf5da76050aee810f81217fea49eff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f320483c8d4df1bd9f114efda382844 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d43c24ea5a09a10dbe38b4f1a06e929 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7442-9251 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e68e3635f64dd06387de20dfed61a21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3bc2424969d905ada8b8924f3ef4c321 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60970449f1c62beea7b56f7f42339831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_899ff78c108ce8b91f05384f69154459 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9cb147e609d7cd8c45bd393310552a8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eedf3993640f6f82ef120b20e445052b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7109-4601
date	2020-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-19-0098 https://pubmed.ncbi.nlm.nih.gov/31919137
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1557-3265 https://portal.issn.org/resource/ISSN/1078-0432
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer
discusses	http://id.nlm.nih.gov/mesh/M0024673 http://id.nlm.nih.gov/mesh/M0520000 http://id.nlm.nih.gov/mesh/M0024671 http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0485677 http://id.nlm.nih.gov/mesh/M0240041 http://id.nlm.nih.gov/mesh/M0024670 http://id.nlm.nih.gov/mesh/M0545741 http://id.nlm.nih.gov/mesh/M0484304 http://id.nlm.nih.gov/mesh/M0024955
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055099Q000473 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D013234Q000473 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D055758Q000378 http://id.nlm.nih.gov/mesh/D059002Q000494 http://id.nlm.nih.gov/mesh/D064129Q000473
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011944Q000235 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D016328Q000378 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D016160Q000378 http://id.nlm.nih.gov/mesh/D055099Q000378 http://id.nlm.nih.gov/mesh/D016160Q000235 http://id.nlm.nih.gov/mesh/D064129Q000378 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D064129Q000188 http://id.nlm.nih.gov/mesh/D013234Q000378 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D055748Q000378 http://id.nlm.nih.gov/mesh/D064129Q000235 http://id.nlm.nih.gov/mesh/D055758Q000235 http://id.nlm.nih.gov/mesh/D016159Q000378 http://id.nlm.nih.gov/mesh/D016159Q000235 http://id.nlm.nih.gov/mesh/D055748Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95858a7883c26280557b4db19d204c39 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2d8cbd07f21be8cc9f8611c26faef88e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9455a7be1a7c0dbb6de4ba8898dff00c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6657 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6662

Total number of triples: 93.